NOX4 and Parkinson disease: Our findings build on these known effects within the context of neurodegeneration, showing that both agents inhibit the glial redox-inflammatory cascade and protect mitochondrial health by reducing NOX4-derived oxidative stress, which ultimately aids in structural and functional recovery in the PD brain.